Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.
Mult Scler Relat Disord
; 60: 103724, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35272145
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2022
Document type:
Article
Country of publication:
Netherlands